Literature DB >> 29722816

Higher Cord Blood Levels of Fatty Acids in Pregnant Women With Type 1 Diabetes Mellitus.

Josip Djelmis1, Marina Ivaniševic1, Gernot Desoye2, Mireille van Poppel3, Edina Berberovic4, Dragan Soldo5, Slavko Oreskovic1.   

Abstract

Context: Type 1 diabetes mellitus (T1DM) is associated with a disturbance of carbohydrate and lipid metabolism. Objective: To determine whether T1DM alters maternal and neonatal fatty acid (FA) levels. Design: Observational study. Setting: Academic hospital. Patients: Sixty pregnant women (30 women with T1DM with good glycemic control and 30 healthy women) were included in the study. Maternal blood, umbilical vein, and artery blood samples were collected immediately upon delivery. Following lipid extraction, the FA profiles of the total FA pool of maternal serum and umbilical vein and artery serum were determined by gas chromatography.
Results: Total FA concentration in maternal serum did not differ between the study groups; it was significantly higher in umbilical vein serum of the T1DM group compared with that in the control group [median (interquartile range)]: T1DM 2126.2 (1446.4 to 3181.3) and control 1073.8 (657.5 to 2226.0; P < 0.001), and in umbilical artery vein serum: T1DM 1805.7 (1393.1 to 2125.0) and control 990.0 (643.3 to 1668.0; P < 0.001). Composition of FAs in umbilical vein serum showed significantly higher concentrations of saturated, monounsaturated, and polyunsaturated FAs (SFAs, MUFAs, and PUFAs, respectively) in the T1DM group than compared with those in the control group (P = 0.001). Furthermore, cord blood levels of leptin (P < 0.001), C-peptide (P < 0.001), and insulin resistance (P = 0.015) were higher in the T1DM group compared with controls.
Conclusion: The neonates born to mothers with T1DM had higher concentrations of total FAs, SFAs and MUFAs, as well as PUFAs, compared with control newborns.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29722816     DOI: 10.1210/jc.2018-00272

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.

Authors:  Marina Ivanisevic; Josip Djelmis
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

2.  Awakened Beta-Cell Function Decreases the Risk of Hypoglycemia in Pregnant Women with Type 1 Diabetes Mellitus.

Authors:  Josip Delmis; Marina Ivanisevic
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

3.  Analgesic Effects of Epidural Labor Analgesia at Different Periods and Its Effects on Maternal and Infant Outcomes and MiRNA-146b Level.

Authors:  Lihong Wang; Hui Liu; Ye Duan; Qingyu Cheng; Suhua Feng
Journal:  J Healthc Eng       Date:  2021-11-25       Impact factor: 2.682

4.  Supplementation of EPA and DHA in pregnant women with type 1 diabetes mellitus.

Authors:  Marina Ivanisevic; Marina Horvaticek; Karlo Delmis; Josip Delmis
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

5.  Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort.

Authors:  Antonio Gázquez; María J Giménez-Bañón; María T Prieto-Sánchez; Carmen Martínez-Graciá; Clara Suárez; Marina Santaella-Pascual; Lina Galdo-Castiñeira; Carmen Ballesteros-Meseguer; Jesús Vioque; Miriam Martínez-Villanueva; Francisco Avilés-Plaza; José A Noguera-Velasco; Eva Morales; Luís García-Marcos; Elvira Larqué
Journal:  Nutrients       Date:  2021-03-04       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.